Loading viewer...
investor_presentation
Format: PDF investor_presentation
GMS investor presentation dated August 2018.
Investor Presentation
Safe Harbor and Basis of Presentation
Forward -Looking Statement Safe Harbor -This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation
Reform Act of 1995. All of these forward -looking statements are based on estimates and assumptions made by our management that, although believed by
us to be reasonable, are inherently uncertain. Examples of forward -looking statements include those related to net sales, gross profit, gross margins, capital
expenditures and market share growth, as well as non-GAAP financial measures such as Adjusted EBITDA, the ratio of debt-to-Adjusted EBITDA, adjusted
net income and base business sales, including any management expectations or outlook for fiscal 2019 and beyond. In addition, statements regarding
potential acquisitions and future greenfield locations and statements regarding the impact of the recent tax legislation, fis cal2018 and 2019 effective tax
rates and the expected use of tax savings are forward -looking statements, as well as statements regarding the markets in which the Company or Titan
operates, product expansion opportunities and the potential for growth in the commercial, residential and repair and remodeli ng,or R&R, markets. In
addition, statements relating to the Titan acquisition, including the combination of best practices, statements regarding expect ed synergies, cost savings,
margin improvement, expected accretion and its expected contribution to the Company’s Adjusted EBITDA for the eleven months endi ng April 30, 2019, are
forward-looking statements. Forward -looking statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental
and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from the forward-looking
statements. These risks and uncertainties may include, among other things: changes in the prices, margin, supply, and/or demand for products which we
distribute; general economic and business conditions in the United States and Canada; the activities of competitors; changes in significant operating
expenses; changes in the availability of capital and interest rates; adverse weather patterns or conditions; acts of cyber intrusion; variations in the
performance of the financial markets, including the credit markets; the possibility that the expected synergies and cost savings and financial impacts from the
Titan acquisition will not be realized, or will not be realized within the expected time period; the risk that the GMS and Titan businesses will not be integrated
successfully; disruption from the transaction making it more difficult to maintain business and operational relationships an d to accomplish other GMS
objectives; the risk of customer attrition; and other factors described in the "Risk Factors" section in our Annual Report on Form 10 -K for the fiscal year
Preview truncated — download the full document for the complete content.
investor_presentation
32 Pages
Cantel Medical Corporation
Cullinan Therapeutics Autoimmune Disease Strategy 2024
investor_presentationinvestor_presentation
25 Pages
Cullinan Therapeutics, Inc.
investor_presentation
Athersys
investor_presentation
TSXV.TRU